World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
86691
World Ranking
5409
National Ranking
156

Overview

Michel Komajda is affiliated with Université Paris Cité in France and has a research focus primarily in the field of Medicine, with significant contributions to Cardiology and Cardiovascular Medicine.

The main subjects of Komajda's research include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, and Diabetes Treatment and Management. Additional topics investigated encompass Heart Rate and Cardiovascular Health, Healthcare Systems and Practices, Acute Myocardial Infarction Research, and Pancreatic Function and Diabetes.

Frequent coauthors collaborating with Komajda include Romain Cador, P. Abassade, Luigi Tavazzi, Gilles Châtellier, and Hélène Beaussier.

Komajda has published extensively in cardiovascular and heart failure research journals. Frequent publication venues include:

  • Archives of Cardiovascular Diseases Supplements
  • Archives of cardiovascular diseases
  • JACC Heart Failure
  • European Journal of Heart Failure
  • Annales de Cardiologie et d Angéiologie

Selected recent papers authored by or involving Michel Komajda are:

  • "Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure," 2020, New England Journal of Medicine
  • "Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction," 2020, Circulation
  • "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial," 2021, Circulation
  • "Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23," 2021, European Heart Journal
  • "The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials," 2021, JACC Heart Failure

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • Effects of Torcetrapib in Patients at High Risk for Coronary Events

    Philip J. Barter;Mark Caulfield;Mats Eriksson;Scott M Grundy

  • Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

    Karl Swedberg;John Cleland;Henry Dargie;Helmut Drexler

  • Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

    Karl Swedberg;Michel Komajda;Michael Böhm;Jeffrey S Borer

  • Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

    Philip A. Poole-Wilson;Karl Swedberg;John G.F. Cleland;Andrea Di Lenarda

  • Irbesartan in patients with heart failure and preserved ejection fraction

    Barry M. Massie;Peter E. Carson;John J. McMurray;Michel Komajda

  • The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

    J.G.F Cleland;K Swedberg;F Follath;M Komajda

  • Rosuvastatin in Older Patients with Systolic Heart Failure

    John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm

  • Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

    Philip D. Home;Stuart J. Pocock;Henning Beck-Nielsen;Paula S. Curtis

  • EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

    Markku S. Nieminen;Dirk Brutsaert;Kenneth Dickstein;Helmut Drexler

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Deepak L. Bhatt;Michael Szarek;P. Gabriel Steg;Christopher P. Cannon

  • Hypertrophic Cardiomyopathy Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy

    Pascale Richard;Philippe Charron;Lucie Carrier;Céline Ledeuil

  • Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

    Piotr Ponikowski;Dirk J. van Veldhuisen;Josep Comin-Colet;Georg Ertl

  • Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

    Michael Böhm;Karl Swedberg;Michel Komajda;Jeffrey S Borer

  • State of the art: using natriuretic peptide levels in clinical practice.

    Alan Maisel;Alan Maisel;Christian Mueller;Kirkwood Adams;Stefan D. Anker

  • Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Philip D. Home;Stuart J. Pocock;Henning Beck-Nielsen;Ramón Gomis

  • Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice : a position statement of the ESC working group on myocardial and pericardial diseases

    Yigal M Pinto;Perry M Elliott;Eloisa Arbustini;Yehuda Adler

  • The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.

    M. Komajda;F. Follath;K. Swedberg;J. Cleland

Frequent Co-Authors

Ketty Schwartz
Ketty Schwartz Grenoble Alpes University
Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Robert S. McKelvie
Robert S. McKelvie University of Western Ontario
John J.V. McMurray
John J.V. McMurray University of Glasgow
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Inder S. Anand
Inder S. Anand University of Minnesota
Karl Swedberg
Karl Swedberg University of Gothenburg
Gisèle Bonne
Gisèle Bonne Université Paris Cité
Ian Ford
Ian Ford University of Glasgow
Eloisa Arbustini
Eloisa Arbustini Policlinico San Matteo Fondazione

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a variety of online degree and certification options. If you’re looking to advance quickly in nursing, the 9 month lpn program offers a fast-track route to becoming a Licensed Practical Nurse, enabling you to start working sooner.

For nurses seeking leadership or advanced clinical roles, consider the convenience of a 1 year dnp program online. This allows registered nurses to earn a Doctor of Nursing Practice rapidly while balancing work and life commitments.

Those interested in mental health services should explore bsn to np programs online, which prepare candidates to become Psychiatric Mental Health Nurse Practitioners. These programs offer flexibility for bachelor’s-trained nurses wishing to specialize without delaying their careers.

Alternatively, if your interests lie more in the management and administrative side of healthcare, an online master of health administration degree can be a smart choice, providing essential skills for leadership roles in hospitals, clinics, and healthcare organizations.

Best Scientists Citing Michel Komajda

Trending Scientists